Methods And Medicament For Inhibition The Expression Of A Defined Gene

Patent No. EP1798285 (titled "Methods And Medicament For Inhibition The Expression Of A Defined Gene") was filed by Alnylam Europe on Jan 29, 2000. The application was issued on Mar 15, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SILENCE THERAPEUTICSDec 15, 2017CMS CAMERON MCKENNA NABARRO OLSWANG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1798285

ALNYLAM EUROPE
Application Number
EP06025389A
Filing Date
Jan 29, 2000
Status
Revoked
Jun 28, 2019
Publication Date
Mar 15, 2017